{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:57:49Z","timestamp":1791705469886,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.09.108","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T07:54:03Z","timestamp":1318233243000},"page":"9691-9696","source":"Crossref","is-referenced-by-count":8,"title":["The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus"],"prefix":"10.1016","volume":"29","author":[{"given":"Karen L.","family":"Denzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chas","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollyce","family":"Hartzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Hembrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Holechek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Buller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (1)","key":"10.1016\/j.vaccine.2011.09.108_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antivir Res"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.09.108_bib0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.09.108_bib0015","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1073\/pnas.0431131100","article-title":"A role for Z-DNA binding in vaccinia virus pathogenesis","volume":"100","author":"Kim","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2011.09.108_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(91)90768-7","article-title":"Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase","volume":"185","author":"Watson","year":"1991","journal-title":"Virology"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2011.09.108_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/viro.1993.1292","article-title":"Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA","volume":"194","author":"Chang","year":"1993","journal-title":"Virology"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.09.108_bib0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.virol.2004.03.012","article-title":"Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L","volume":"324","author":"Langland","year":"2004","journal-title":"Virology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.09.108_bib0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms","volume":"29","author":"Perdiguero","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2011.09.108_bib0040","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1128\/JVI.00607-06","article-title":"Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins","volume":"80","author":"Langland","year":"2006","journal-title":"J Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.09.108_bib0045","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","article-title":"Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model","volume":"75","author":"Brandt","year":"2001","journal-title":"J Virol"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.09.108_bib0050","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.vaccine.2008.03.044","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination","volume":"26","author":"Jentarra","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.09.108_bib0055","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/v2091918","article-title":"Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics","volume":"2","author":"Parker","year":"2010","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.108_bib0060","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/135965350801300703","article-title":"Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001","volume":"13","author":"Parker","year":"2008","journal-title":"Antivir Ther"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.09.108_bib0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6822(92)90445-U","article-title":"Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene","volume":"187","author":"Chen","year":"1992","journal-title":"Virology"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2011.09.108_bib0070","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.vaccine.2003.10.022","article-title":"Mouse neurotoxicity test for vaccinia-based smallpox vaccines","volume":"22","author":"Li","year":"2004","journal-title":"Vaccine"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2011.09.108_bib0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.09.108_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.09.108_bib0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/0300985810372506","article-title":"Establishing efficacy of human products using animals: the US food and drug administration's \u201canimal rule\u201d","volume":"47","author":"Snoy","year":"2010","journal-title":"Vet Pathol"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2011.09.108_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0042-6822(03)00520-8","article-title":"The genomic sequence of ectromelia virus, the causative agent of mousepox","volume":"317","author":"Chen","year":"2003","journal-title":"Virology"},{"issue":"January (Pt 1)","key":"10.1016\/j.vaccine.2011.09.108_bib0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1099\/vir.0.19565-0","article-title":"Poxvirus genomes: a phylogenetic analysis","volume":"85","author":"Gubser","year":"2004","journal-title":"J Gen Virol"},{"issue":"October (Pt 10)","key":"10.1016\/j.vaccine.2011.09.108_bib0100","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox","volume":"86","author":"Esteban","year":"2005","journal-title":"J Gen Virol"},{"issue":"Oct 13","key":"10.1016\/j.vaccine.2011.09.108_bib0135","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1016\/j.vaccine.2011.07.140","article-title":"The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus","volume":"29","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2011.09.108_bib0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2011.09.108_bib0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2005.06.043","article-title":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","volume":"341","author":"Coulibaly","year":"2005","journal-title":"Virology"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.09.108_bib0115","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J Virol"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.09.108_bib0120","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1073\/pnas.89.13.6070","article-title":"Beta 2-microglobulin-CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses","volume":"89","author":"Spriggs","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.09.108_bib0125","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.108_bib0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/153567600400900302","article-title":"The infectious dose of variola (smallpox) virus","volume":"9","author":"Nicas","year":"2004","journal-title":"Appl Biosafety"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:51:58Z","timestamp":1686390718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11015507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":27,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0264410X11015507"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.108","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}